Palliative Care and Decision Making in Advanced Heart Failure

Current Treatment Options in Cardiovascular Medicine

Volumn 17, Issue 2, 2015, Pages

  LeMond, Lisa ^a   Camacho, S Albert ^a   Goodlin, Sarah J ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Advance directives; Advanced heart failure; Cognitive impairment; Implantable cardioverter defibrillator (ICD); Left ventricular assist device (LVAD); Palliative care

Indexed keywords

ASSISTED CIRCULATION; CARDIAC EQUIPMENT; CLINICAL DECISION MAKING; HEALTH STATUS; HEART FAILURE; HUMAN; PALLIATIVE THERAPY; PATIENT DECISION MAKING; PHYSICIAN; REVIEW; TERMINAL CARE;

EID: 84924778372     PISSN: 10928464     EISSN: 15343189     Source Type: Journal    
DOI: 10.1007/s11936-014-0359-5     Document Type: Review

References (35)

1. Yancy CW, Jessup M, Butler J, et al. ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–327. Summary of guideline-based therapy for the treatment of heart failure.
2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–e209.
3. Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010;12(5):434–43.
4. Miller LW. Left ventricular assist devices are underutilized. Circulation. 2005;123(14):1552–8.
5. Nohria A, Lewis E, Stevenson LW. Medical Management of Advanced Heart Failure. J Am Med Assoc. 2002;287(5):628–40.
6. Allen LA et al. Decision Making in Advanced Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2012;125:1928–52. Most recent expert guidelines for decision-making in advanced HF. This is a comprehensive document summarizing recommendations on each of the key components.
7. Goodlin SJ, Quill TE, Arnold RM. Communication and Decision-Making About Prognosis in Heart Failure Care. J Cardiac Fail. 2008;14:106–13.
8. Bekelman DB, Rumsfeld J, Havranek E. Symptom Burden, Depression, and Spiritual Well-Being: A Comparison of Heart Failure and Advanced Cancer Patients. J Gen Intern Med. 2009;24(5):592–8.
9. Forest SJ, Bello R, Friedmann P, et al. Readmissions After Ventricular Assist Device: Etiologies, Patterns, and Days Out of Hospital. Ann Thorac Surg. 2013;95:1276–81. This paper investigates readmission patterns after LVAD implantation amongst a mixed cohort of LVAD patients. This group included destination therapy and bridge to transplant patients.
10. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424–33.
11. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–7.
12. Haga K, Murray S, Reid J, et al. Identifying community based chronic heart failure patients in the last year of life: a comparison of the Gold Standards Framework Prognostic Indicator Guide and the Seattle Heart Failure Model. Heart. 2012;98:579–83.
13. Chyu J, Fonarow G, Tseng C, Horowich T. Four-Variable Risk Model in Men and Women With Heart Failure. Circ Heart Fail. 2014; 7:88-95. A new proposed model for prognostication in advanced HF.
14. Afilalo J, Karunananthan S, Eisenberg MJ, et al. Role of Frailty in Patients With Cardiovascular Disease. Am J Cardiol. 2009;103:1616–21.
15. Afilalo J, Alexander KP, Mack MJ, Maurer MS, Green P, Allen LA, et al. Frailty Assessment in the Cardiovascular Care of Older Adults. J Am Coll Cardiol. 2014;63(8):747–62.
16. Khan H, Kalogeropoulos AP, Georgiopoulo V, et al. Frailty and Risk for Heart Failure in Older Adults, the Health, Aging and Body Composition Study. Am Heart J. 2013;166(5):887–94. This paper identifies frailty as an independent risk factor for poor outcomes in older adults with cardiovascular disease.
17. Pilotto A, Addante F, Franceschi M, et al. Multidimensional Prognostic Index based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ Heart Fail. 2010;3(1):14–20. Highlights the importance of the geriatric assessment tool in older adults with cardiovascular disease.
18. Dodson JA, Truong T, Towle V, et al. Cognitive Impairment in Older Adults with Heart Failure: Prevalence, Documentation, and Impact on Outcomes. Am J Med. 2013;126:120–6. Landmark study on cognitive impairment in geriatric patients with heart failure. This paper demonstrates a high prevalence, low rate of documentation and an association with worse outcomes.
19. Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS Annual Report: Risk Factor Analysis From More Than 6,000 Mechanical Circulatory Support Patients. J Heart Lung Transplant. 2013;32:141–56.
20. Maltby MC, Flattery M, Burns B, et al. Psychosocial assessment of candidates and risk classification of patients considered for durable mechanical circulatory support. J Heart Lung Transplant. 2014;S1053-2498(14):01089–4. Psychosocial candidacy for LVAD implantation is difficult to assess and highly subjective. This easy to use tool allows clinicians to have a more objective means of estimating outcomes.
21. Dunlay SM, Park S, Joyce L, et al. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014;33(4):359–65. Frailty determines outcomes in cardiovascular illness. These authors studied the association between frailty and worsened outcomes after LVAD implantation.
22. McIlvennan CK, Allen L, Nowels C, et al. Decision Making for Destination Therapy Left Ventricular Assist Devices. Circ Cardiovasc Qual Outcomes. 2014;7:274–380. Summary of the means by which patients reached decisions to either accept or decline destination-therapy LVAD. This paper helps the provider to understand what factors influence decision making in this population of advanced HF patients.
23. Jakovljevic DG, McDiarmid A, Hallsworth K, et al. Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life. Am J Cardiol. 2014;114(1):88–93.
24. Mello IT, Ashcraft AS. The meaning in life for patients recently hospitalized with congestive heart failure. Am Assoc Nurse Prac. 2014;26:70–6. doi:10.1002/2327-6924.12047.
25. LeMond LM, Allen L. Palliative Care and Hospice in Advanced Heart Failure. Prog Cardiovasc Dis. 2011;54:168–78.
26. Goodlin SJ, Hauptman P, Arnold R, et al. Consensus Statement: Palliative and Supportive Care in Advanced Heart Failure. J Card Fail. 2004;10(3):200–9.
27. Browne S, Macdonald S, May C, Macleod U, Mair FS. Patient, Carer and Professional Perspectives on Barriers and Facilitators to Quality Care in Advanced Heart Failure. PLoS One. 2014;9(3):e93288.
28. Whellan DJ, Goodlin S, Dickinson M, et al. End-of-Life Care in Patients with Heart Failure. J Card Fail. 2014;20(2):121–134. This is a white paper and review of available evidence on end of life care for persons with heart failure.
29. Greener DT, Quill T, Amir, Szydlowshi J, Gramling R. Palliative Care Referral among Patients Hospitalized with Advanced Heart Failure. J Pall Med 2014; (17): Epub ahead of print. Summarizes a single-center’s referral patterns to Palliative Care.
30. Smith R. A Good Death. An Important Aim for Health Services and For Us All. BJM. 2000;320:129–30.
31. Goodlin SJ. Palliative Care in Congestive Heart Failure. J Am Coll Cardiol. 2009;54(5):386–96.
32. Notarius CF, Morris B, Floras JS. Caffeine prolongs exercise duration in heart failure. J Card Fail. 2006;12(3):220–6.
33. Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R. Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med. 2013;173(5):377–9. Explores patient preferences for deactivation of ICD therapy. Important to understand patient beliefs surrounding their devices.
34. Westerdahl A, Sjöblom J, Mattiasson A, et al. Implantable Cardioverter-Defibrillator Therapy Before Death: High Risk for Painful Shocks at End of Life. Circulation. 2014;129:422–9. Study that determined the frequency of ICD shocks at the end of life by doing postmortem interrogation of these devices.
35. Goldstein NE, Kallman J, Kutner J, et al. A Study to Improve Communication Between Clinicians and Patients With Advanced Heart Failure: Methods and Challenges Behind the Working to Improve Discussions About Defibrillator Management Trial. J Pain Symptom Manag. 2014;S0885-3924(14):00216–4. Helpful article for formulating discussions about end of life management in patients with ICDs.